Medicare DES Rates Sustained; CMS Cites Paltry Data To Back DRG Change

CMS will reconsider proposals to restructure the drug-eluting stent DRGs in 11 months after more data become available to support industry and physician assertions of significant cost differences between complex and non-complex cases